Curaleaf International announced as main partner of Cannabis Europa conference in London

Curaleaf International, a leading global cannabis company, has been announced as the main partner of Cannabis Europa, to be held in London on June 25 and 26, 2024.

Cannabis Europa is Europe's leading conference series connecting influential leaders in science, policy and business, helping to build a responsible and efficient European cannabis industry that promotes access and growth. Focusing on innovation, regulation and investment opportunities within the rapidly evolving cannabis industry, the conference serves as a platform for business leaders, policymakers, investors, patients and advocates to collaborate and drive progress.

As a principal partner of Cannabis Europa, Curaleaf International brings its unrivalled expertise and commitment to advancing the medical cannabis industry in Europe. As a market leader on a rapid growth trajectory, Curaleaf International is driven by research and the highest degree of scientific rigor, setting the standard for the industry.

The European medical cannabis market is expected to be worth nearly €2.2 billion and serve nearly 1.5 million patients in the region by 2027, according to forecasts published by Prohibition Partners in The European Cannabis Report: 8th Edition.

«We are delighted to partner with Cannabis Europa on this groundbreaking event,» said Juan Martinez, Director of Curaleaf International. «As the global leader in cannabis, we are deeply committed to driving positive change and shaping the future of the industry. Cannabis Europa provides an invaluable platform for collaboration, innovation and education, and we look forward to contributing to meaningful discussions and insights at the conference.»

Commenting on the partnership, Stephen Murphy, co-founder and CEO of Cannabis Europa and Prohibition Partners, said, «Since 2018, Cannabis Europa has been a destination for true industry and political leaders to converge and shape the future of cannabis. We're delighted to welcome Curaleaf International as a key partner of Cannabis Europa, which will be held this year in London in June. As a global leader in the cannabis industry, Curaleaf International supports positive change in healthcare and sets standards for an emerging industry.

The conference Cannabis Europa in London will bring together a wide range of speakers, including industry experts, politicians, healthcare professionals and investors, to discuss topics such as medical advances, regulatory frameworks, investment opportunities and global market trends.

For more information about Cannabis Europa and to register for the conference, please visit : www.cannabis-europa.com.

For media inquiries or interview requests, please contact :

Mike Hoban
Marketing and Communications Manager
Prohibition Partners
+44(0)7841 697 433
[email protected]

About Cannabis Europa

Cannabis Europa conferences connect influential leaders in science, policy and business, helping to build a responsible and efficient European cannabis industry that promotes innovation, access and growth. Our events are a catalyst for policy change and a platform for cannabis-related businesses to connect with mainstream brands.

Cannabis Europa's inaugural conference took place in 2018 at London's Barbican. Within a month, the Home Office recognized the medical benefits of cannabis and revised its stance on its use as medicine, beginning a path towards patient access. Since then, Cannabis Europa has been forging ahead to shape the future of cannabis, organizing industry-leading conferences in: Paris (2019), London (2019), Toronto (2019), New York (2019), Madrid (2020) and London (2021, 2022, 2023).

About Curaleaf International

Curaleaf International is one of Europe's largest vertically integrated cannabis companies. Its unique supply and distribution network for the European market combines pioneering science and research with state-of-the-art cultivation, extraction and production. In a context of rapid growth, the company's focus on quality and expertise aims to ensure the provision of safe, reliable and effective care for all.
Curaleaf International's network of subsidiaries includes Curaleaf Clinic, Curaleaf Pharmacy and Curaleaf Laboratories in the UK. It also includes the Terra Verde cultivation center in Portugal, the Medalchemy research and development site in Spain, the wholesaler and distributor Four20 Pharma in Germany and the Polish wholesaler Can4Med.

Curaleaf International is part of Curaleaf Holdings, Inc., a leading global cannabis company. Curaleaf is listed on the Toronto Stock Exchange (TSX) and trades on the OTCQX under the symbol CURLF.